Related references
Note: Only part of the references are listed.Intranasal immunization of mice with a formal in-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection
John W. Mapletoft et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome
Mirjam Kool et al.
JOURNAL OF IMMUNOLOGY (2008)
The Balance between Plasmacytoid DC versus Conventional DC Determines Pulmonary Immunity to Virus Infections
Joost J. Smit et al.
PLOS ONE (2008)
MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus
Vijay G. Bhoj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production
Brian D. Rudd et al.
VIRAL IMMUNOLOGY (2007)
Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus
Andrey A. Kolokoltsov et al.
JOURNAL OF VIROLOGY (2007)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
Herren Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection
Brian D. Rudd et al.
JOURNAL OF IMMUNOLOGY (2007)
Retinoic acid-inducible gene I mediates early antiviral response and toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells
Ping Liu et al.
JOURNAL OF VIROLOGY (2007)
C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression
Guillermina A. Melendi et al.
JOURNAL OF VIROLOGY (2007)
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Amanda L. Gavin et al.
SCIENCE (2006)
A potential molecular mechanism for hypersensitivity caused by formalin- inactivated vaccines
Amin Moghaddam et al.
NATURE MEDICINE (2006)
Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-κB-dependent mechanism
Caroline A. Lindemans et al.
JOURNAL OF IMMUNOLOGY (2006)
Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection
BD Rudd et al.
JOURNAL OF IMMUNOLOGY (2006)
Control of B-cell responses by Toll-like receptors
C Pasare et al.
NATURE (2005)
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin
FP Polack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles
FP Polack et al.
NATURE MEDICINE (2003)
Mechanism of neutralization of influenza virus infectivity by antibodies
M Knossow et al.
VIROLOGY (2002)
A role for immune complexes in enhanced respiratory syncytial virus disease
FP Polack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
An antibody that prevents the hemagglutinin low pH fusogenic transition
C Barbey-Martin et al.
VIROLOGY (2002)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Share Paper
